Metrics
- Price
- $56.90
- Market Cap $M
- 8,710
- Rel Volume
- 0.96
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- -3.10%
- 1D
- +1.44%
- 1W
- +2.12%
- 1M
- +14.07%
- 1M Slope
- +17.68%
- 6M Range
- 119.23%
- Score
- 74.3
- Sharp
- 5.7
Volume
Profile
TG Therapeutics develops and commercializes innovative therapies for B-cell diseases, with a focus on treatments for multiple sclerosis and blood cancers.
Biotech
Pharmaceuticals
Healthcare